Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of povorcitinib phosphate tablets in adult Chinese patients with nonsegmental vitiligo
CTR20263534Phase 3Active
- Sponsor
- Hainan Demei Pharmaceutical Technology
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of povorcitinib in nonsegmental vitiligo, sponsored by Hainan Demei Pharmaceutical Technology. Started Sep 2026; status: active.
02
Drugs
povorcitinib
03
Conditions
nonsegmental vitiligo
Beyond the preview
Go deeper on CTR20263534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263534.